• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病患者在无植入式除颤器保护的情况下心脏骤停后的长期生存情况。

Long-Term Survival Following Cardiac Arrest Without Implantable Defibrillator Protection in a Hypertrophic Cardiomyopathy Patient.

作者信息

Cetin Mustafa, Ucar Ozgul, Canbay Alper, Cetin Zehra Guven, Cicekcioglu Hulya, Diker Erdem

机构信息

Ataturk Chest Disease and Chest Surgery Education and Research Hospital, Department of Cardiology, Sanatoryum Caddesi, 06280, Ankara, Turkey.

Ankara Numune Education and Research Hospital, Department of Cardiology, Talatpasa Bulvari, 06110, Ankara, Turkey.

出版信息

Cardiol Res. 2011 Jun;2(3):132-135. doi: 10.4021/cr46w. Epub 2011 May 20.

DOI:10.4021/cr46w
PMID:28352382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5358319/
Abstract

Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people. Implantable cardioverter defibrillator (ICD) is the optimal therapy in patients with HCM, both for primary or secondary prevention of sudden death. Left ventricular systolic function in HCM is usually normal. However, in few patients, HCM has been reported to progress to a state that is characterized by left ventricular dilation and systolic dysfunction, resembling dilated cardiomyopathy (DCM). Although arrhythmias are common in HCM, advanced or complete atrioventricular block (AV) is very rare. This case report describes a HCM patient who progressed to DCM with advanced AV block and survived 31 years following cardiac arrest without ICD protection.

摘要

肥厚型心肌病(HCM)是年轻人心脏性猝死最常见的原因。植入式心脏复律除颤器(ICD)是HCM患者的最佳治疗方法,可用于猝死的一级或二级预防。HCM患者的左心室收缩功能通常正常。然而,少数患者的HCM已发展为以左心室扩张和收缩功能障碍为特征的状态,类似于扩张型心肌病(DCM)。虽然心律失常在HCM中很常见,但高级或完全性房室传导阻滞(AV)非常罕见。本病例报告描述了一名HCM患者,其发展为伴有高级AV阻滞的DCM,在心脏骤停后未接受ICD保护的情况下存活了31年。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/06eb9d50bebc/cr-02-132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/71c10b460e15/cr-02-132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/bf7510df8c6b/cr-02-132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/06eb9d50bebc/cr-02-132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/71c10b460e15/cr-02-132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/bf7510df8c6b/cr-02-132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/5358319/06eb9d50bebc/cr-02-132-g003.jpg

相似文献

1
Long-Term Survival Following Cardiac Arrest Without Implantable Defibrillator Protection in a Hypertrophic Cardiomyopathy Patient.肥厚型心肌病患者在无植入式除颤器保护的情况下心脏骤停后的长期生存情况。
Cardiol Res. 2011 Jun;2(3):132-135. doi: 10.4021/cr46w. Epub 2011 May 20.
2
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.植入式心脏复律除颤器与肥厚型心肌病心脏性猝死的预防
JAMA. 2007 Jul 25;298(4):405-12. doi: 10.1001/jama.298.4.405.
3
Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.植入式心脏复律除颤器治疗与肥厚型心肌病合并心室中部梗阻患者的猝死风险分层:单中心经验
Int J Cardiol. 2016 Jul 1;214:419-22. doi: 10.1016/j.ijcard.2016.03.231. Epub 2016 Apr 4.
4
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.肥厚型心肌病中使用植入式除颤器进行风险分层和预防猝死的当代策略。
Heart Rhythm. 2016 May;13(5):1155-1165. doi: 10.1016/j.hrthm.2015.12.048. Epub 2016 Jan 1.
5
Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.植入式心脏复律除颤器治疗肥厚型心肌病心脏性猝死一级和二级预防的疗效
Pacing Clin Electrophysiol. 2003 Sep;26(9):1887-96. doi: 10.1046/j.1460-9592.2003.00285.x.
6
Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy.肥厚型心肌病患者植入式心脏转复除颤器治疗:SIMPLE 子研究。
Heart Rhythm. 2018 Mar;15(3):386-392. doi: 10.1016/j.hrthm.2017.11.020. Epub 2017 Nov 20.
7
Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy: Two case reports.肥厚型心肌病心尖部心室颤动与心脏骤停:两例报告
World J Clin Cases. 2021 Dec 16;9(35):11102-11107. doi: 10.12998/wjcc.v9.i35.11102.
8
[Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].肥厚型心肌病(HCM)猝死的预防:HCM患者植入式除颤器
Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):297-302.
9
Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.肥厚型心肌病扩张期的临床特征和结局:来自日本登记数据的报告。
J Cardiol. 2013 Jan;61(1):65-70. doi: 10.1016/j.jjcc.2012.08.010. Epub 2012 Oct 15.
10
[Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].[家族性肥厚型心肌病中的心脏性猝死。高危患者的识别]
Dtsch Med Wochenschr. 2005 May 6;130(18):1150-4. doi: 10.1055/s-2005-866802.

本文引用的文献

1
Long-term survival after cardiac arrest in hypertrophic cardiomyopathy.肥厚型心肌病心脏骤停后的长期生存情况。
Heart Rhythm. 2009 Jul;6(7):993-7. doi: 10.1016/j.hrthm.2009.03.014. Epub 2009 Mar 11.
2
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.植入式心脏复律除颤器与肥厚型心肌病心脏性猝死的预防
JAMA. 2007 Jul 25;298(4):405-12. doi: 10.1001/jama.298.4.405.
3
Prevalence of systolic impairment in an unselected regional population with hypertrophic cardiomyopathy.
肥厚型心肌病非选择性区域人群中收缩功能障碍的患病率。
Am J Cardiol. 2006 Nov 1;98(9):1269-72. doi: 10.1016/j.amjcard.2006.05.063. Epub 2006 Sep 18.
4
Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese.日本人中由心脏肌球蛋白结合蛋白C基因的奠基者移码缺失突变引起的肥厚型心肌病的终身左心室重塑。
J Am Coll Cardiol. 2005 Nov 1;46(9):1737-43. doi: 10.1016/j.jacc.2005.05.087. Epub 2005 Oct 10.
5
Abnormal His-Purkinje system conduction leading to complete atrioventricular block in patients with hypertrophic cardiomyopathy: a report of 3 cases.
Jpn Heart J. 2004 Mar;45(2):347-52. doi: 10.1536/jhj.45.347.
6
Hypertrophic cardiomyopathy: a systematic review.肥厚型心肌病:一项系统综述。
JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308.
7
Hypertrophic cardiomyopathy complicated by severe bradycardias: a pedigree report.肥厚型心肌病合并严重心动过缓:一份家系报告。
Clin Cardiol. 2002 Feb;25(2):76-80. doi: 10.1002/clc.4950250207.
8
Heart rate variability in hypertrophic obstructive cardiomyopathy: association with functional classification and left ventricular outflow gradients.肥厚型梗阻性心肌病的心率变异性:与功能分级及左心室流出道梯度的关联
Int J Cardiol. 2001 Feb;77(2-3):281-6. doi: 10.1016/s0167-5273(00)00447-2.
9
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.植入式心脏复律除颤器对肥厚型心肌病患者预防猝死的疗效。
N Engl J Med. 2000 Feb 10;342(6):365-73. doi: 10.1056/NEJM200002103420601.
10
Torsades de pointes in a case of hypertrophic cardiomyopathy with special reference to the pathologic findings of the heart including the conduction system.肥厚型心肌病患者发生尖端扭转型室速,特别提及心脏包括传导系统的病理检查结果
Jpn Heart J. 1999 Mar;40(2):233-8. doi: 10.1536/jhj.40.233.